MentionFox
Home › funding signals › Enveric Biosciences, Inc.
Form D · on the record

Enveric Biosciences — $5M Form D filing, May 2026

Enveric Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-05-04.

Enveric Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 4, 2026. Enveric Biosciences, Inc. trades on Nasdaq as ENVB; it was formerly AMERI Holdings, Inc. The filing reports $5M sold. Its industry group is Biotechnology. It names Joseph Tucker (Chief Executive Officer and Director), Kevin Coveney (Chief Financial Officer), Michael Webb (Director) (SEC Form D, May 4, 2026).

Sell to companies like Enveric Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

5 more Biotechnology raises in Massachusetts, May 2026 ↓

Is this your company?

Key facts

Run the free check on Enveric Biosciences, Inc. →

Enveric Biosciences, Inc.

New Form D on file · 2026-05-04 · the record

$5M
raise on the record
D
filing
4
investors in
MASSACHUSETTS
based
Open the record →

What the record says

FilingForm D
Filed2026-05-04
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedCAMBRIDGE, MASSACHUSETTS
CIK890821
Accession0000890821-26-000002

Pitching, partnering or investing alongside them? See who really runs and owns Enveric Biosciences, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Enveric Biosciences, Inc., from the filings we hold.

Raised through the same sales agent

H.C. Wainwright & Co., LLC received sales compensation on this raise and on 27 other raises we hold, nearest in date first:

More raises like this

Biotechnology raises by companies based in Massachusetts, filed in May 2026, largest first.

What do you want to do with Enveric Biosciences, Inc.?

Get the full cited report on Enveric Biosciences, Inc.

What the filing shows about Enveric Biosciences, Inc.

  • 4 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Enveric Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Enveric Biosciences, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Enveric Biosciences, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Enveric Biosciences, Inc.'s address as 245 First Street Riverview II 18TH Floor, Cambridge, MA 02142.

What the filing says

  • Offered: $5,000,002. Sold: $5,000,002. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 4 had already invested. (filing)
  • Date of first sale: April 17, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Company engaged in PIPE transaction with certain institutional investors and issued 98,000 shares of common stock, 2,124,233 pre-funded warrants, 2,222,223 series I warrants, and 2,222,223 series J warrants for gross proceeds of approx $5 M.” (filing)
  • On sales commissions and finders' fees: the filing adds “Based on total transaction proceeds of approx $5M. The placement agent also received warrants to purchase up to 155,556 shares of Common Stock at an exercise price equal to $2.8125 per share and payment of expenses and a management fee.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Enveric Biosciences, Inc. See pricing

Is Enveric Biosciences, Inc. a real, registered company?

Enveric Biosciences, Inc. is a registered filer with the SEC (CIK 890821) and has filed since 2025-10-03. 4 filings are on record, the latest on 2026-05-04.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Enveric Biosciences, Inc.?

Enveric Biosciences, Inc.'s Form D of 2026-05-04 names Joseph Tucker, Kevin Coveney, Michael Webb and 4 more as its officers, directors or promoters.

How much has Enveric Biosciences, Inc. raised?

Its new offerings report $6.56M sold across 3 offerings, as its own filings state.

Filing history · 5 filings on this registrant
Form D/A, amended · 2023-04-19 · $12.78MForm D · 2025-10-03Form D · 2025-12-23 · $107KForm D · 2026-02-11 · $1.45MForm D · 2026-05-04 · $5M · this page 2023-04-19 2026-05-04

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $5M, filed week of May 4

Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $5M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Enveric Biosciences, Inc.?

What the filing shows about Enveric Biosciences, Inc.

  • 4 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Enveric Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Enveric Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (enveric.com).

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Enveric Biosciences, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

More on Enveric Biosciences, Inc.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Enveric Biosciences, Inc.: Raised $5M, Form D filed 2026-05-04
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/enveric-biosciences-inc-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Enveric Biosciences raised $5M — SEC Form D filing, May 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/enveric-biosciences-inc-form-d-26000001